Cargando…
Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility
Categorization of patients with COPD as reversible or nonreversible to a bronchodilator may change over time. This post hoc analysis aimed to determine if an individual’s reversibility, when treated as a continuous variable, could predict his/her future response to two short-acting bronchodilators:...
Autores principales: | Pascoe, Steven, Wu, Wei, Zhu, Chang-Qing, Singh, Dave |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010081/ https://www.ncbi.nlm.nih.gov/pubmed/27621609 http://dx.doi.org/10.2147/COPD.S108723 |
Ejemplares similares
-
Which bronchodilator in COPD?
por: Russell, Richard, et al.
Publicado: (2007) -
The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD
por: Singh, Dave, et al.
Publicado: (2018) -
Data Reproducibility and Effectiveness of Bronchodilators for Improving Physical Activity in COPD Patients
por: Minakata, Yoshiaki, et al.
Publicado: (2020) -
Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators
por: Nicolini, Antonello
Publicado: (2012) -
Bronchodilators use in patients with COPD
por: Dong, Yaa-Hui, et al.
Publicado: (2015)